What We're Reading: Page 143
Industry reads hand-picked by our editors
Aug 06, 2021
-
The Wall Street Journal
FDA Covid-19 Vaccine Booster Plan Could Be Ready Within Weeks
-
FierceBiotech
Dicerna drops after mixed data on rival to Alnylam drug
-
Science
A giant trial of COVID-19 treatments is restarting. Here are the drugs it’s betting on
-
Reuters
Gilead says aware of counterfeit HIV medicines being distributed in U.S.
Aug 05, 2021
-
ProPublica
Thousands of Patients Were Implanted With Heart Pumps That the FDA Knew Could Be Dangerous
-
Axios
AbbVie's blockade of cheaper Humira options
-
Healthcare Dive
FTC warns it may challenge deals later as it's hit by 'tidal wave' of merger filings
-
C&EN
How transcription gets its start, in pictures
Aug 04, 2021
-
The New York Times
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Month
-
Bloomberg
SoftBank Build Stake in Roche Worth $5 Billion
-
Endpoints News
Synbio unicorn Zymergen jettisons founding CEO, cuts guidance as customers report lead product doesn't work
-
The Wall Street Journal
Amgen Disputes IRS Claim It Owes $3.6 Billion in Back Taxes
Aug 03, 2021
-
FiercePharma
Bristol Myers pulls an Istodax lymphoma use 10 years after FDA accelerated approval
-
STAT
Even as it breaks biotech’s unwritten rules, Amylyx is raising big money
-
Reuters
Drugmaker Eli Lilly profit hit by weak demand for pandemic drugs
-
Insider
The 24 Biotech Startups That Will Take Off in the Next Year, VCs Say
Aug 02, 2021
-
The Washington Post
FDA vows 'all hands on deck' effort to get Pfizer coronavirus vaccine full approval as quickly as possible
-
MarketWatch
Immunovant Shares Drop After Roivant Opts for Strategic Investment
-
Financial Times
Pfizer and Moderna ramp up EU Covid vaccine prices
-
Reuters
FDA okays Regeneron COVID-19 antibody as preventive in high-risk settings
Jul 30, 2021
-
The Washington Post
‘The war has changed’: Internal CDC document urges new messaging, warns delta infections likely more severe
-
Chemical & Engineering News
Biomanufacturing draws hundreds of millions in investments
-
Bloomberg
Boston's Biotechs Pull Out All the Stops in Hiring Boom 'On Steroids'
-
The Wall Street Journal
Israel to Offer Pfizer Booster Shots to Elderly as Delta Cases Rise
Jul 29, 2021
-
Endpoints News
In CureVac's failure, a possible verdict on the past (and future) of mRNA vaccines
-
Nature
How the coronavirus infects cells — and why Delta is so dangerous
-
MedCity News
AI-driven Deep Genomics gets $180M to turn biology into informational medicines
-
Fierce Biotech
GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer
Previous
